BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06496568-completion@plaintrial.com
DTSTAMP:20261111T062328Z
DTSTART;VALUE=DATE:20280928
SUMMARY:A Study Evaluating Single-agent Inavolisib\, Inavolisib Plus Atezol
 izumab\, and Inavolisib Plus Pembrolizumab in PIK3CA-Mutated Cancers — e
 stimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06496568
URL:https://plaintrial.com/trial/NCT06496568
END:VEVENT
END:VCALENDAR